Delivery Order SPE2DB22D2009-SPE2DB23FM3HL

Award Date 8/17/23
Potential Completion Date 8/18/23
Potential Value $24K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $6,494 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561453819 BOOSTRIX TDAP vaccine syringes. As the prime contractor, Amerisourcebergen will deliver 0.5mL doses of the tetanus, diphtheria, and pertussis vaccine to support DLA immunization programs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period in July 2023. No subcontractors or set aside designations were identified....
The Defense Logistics Agency awarded a $12,319.43 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562236646 BOOSTRIX TDAP vaccine syringes. As the prime contractor, Amerisourcebergen will deliver 0.5ml doses of the tetanus, diphtheria, and pertussis vaccine to support DLA immunization programs. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The delivery order has a period of performance from September 19-20, 2023. No...
The Defense Logistics Agency awarded a $2,020.72 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division to supply 4562193466 BOOSTRIX TDAP vaccine syringes. The single award was issued under an existing indefinite-delivery/indefinite-quantity contract vehicle to provide 0.5ml doses of the tetanus, diphtheria, and acellular pertussis vaccine for administration by injection. Performance will occur at the prime contractor's facility in Conshohocken, Pennsylvania...
The Defense Logistics Agency awarded a $1,409.53 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division for 4561931457 BOOSTRIX TDAP vaccine syringes. The single award was issued under an existing prime vendor contract vehicle to supply 0.5ml doses of the tetanus, diphtheria, and pertussis vaccine for administration to military personnel. Performance will occur at the contractor's facility in Conshohocken, Pennsylvania with delivery required between August...
The Defense Logistics Agency awarded a $61,632 delivery order to Amerisourcebergen Drug Corporation for 4561373721 BOOSTRIX TDAP vaccine syringes. The firm fixed price order is to provide 0.5mL syringes of the tetanus, diphtheria, and pertussis vaccine BOOSTRIX to support DLA immunization programs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period from June 29 to June 30, 2023. No subcontractors or set aside designations were identified....
The Defense Logistics Agency awarded a $2,549.20 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division to provide 4561489128 BOOSTRIX TDAP vaccine syringes. The single day order from July 13-14, 2023 is for the supply of 0.5ml TDAP vaccine syringes to support DLA immunization programs. Amerisourcebergen will fulfill the order from its facility located in Conshohocken, Pennsylvania. No subcontractors or set aside designations were identified. The delivery...
The Defense Logistics Agency awarded a $1,459 delivery order to Amerisourcebergen Drug Corporation for 4561436274 BOOSTRIX TDAP vaccine syringes. The firm fixed price order is valued at one thousand four hundred fifty-nine dollars and twenty-two cents. Performance will take place in Conshohocken, Pennsylvania over a period of three days from July 7 through July 10, 2023. The DLA procures medical supplies and equipment to support Department of Defense programs. This small order for combination...
The Defense Logistics Agency awarded a $24,248 delivery order to Amerisourcebergen Drug Corporation for Boostrix Tdap vaccine syringes. Under the firm fixed price contract, Amerisourcebergen will provide 4,562,194603 units of the 0.5mL syringes to support DLA immunization programs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a three-day period concluding on September 18, 2023. No subcontractors or set aside designations were identified. The...
The Defense Logistics Agency awarded a $2,753.08 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division for 4561931405 BOOSTRIX TDAP vaccine syringes. The single award was issued under an indefinite-delivery/indefinite-quantity contract vehicle to supply 0.5mL doses of the tetanus, diphtheria, and pertussis vaccine for administration to military personnel. Performance will occur at the prime contractor's facility in Conshohocken, Pennsylvania with delivery...
The Defense Logistics Agency awarded a $764.76 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division for 4562193433 BOOSTRIX TDAP vaccine syringes. The vaccines will be delivered to a location in Conshohocken, Pennsylvania by September 18, 2023 to support Department of Defense immunization programs. No additional subcontractors or set aside designations were specified. This delivery order was issued against an existing DLA vaccine contract vehicle to fulfill...
  • SPE2DB22D2009
    Indefinite Delivery Contract
  • SPE2DB22D2009-SPE2DB23FM3HL
    Delivery Order

The Defense Logistics Agency awarded a $24,248.64 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561847779 BOOSTRIX TDAP vaccine syringes. The single award was issued against an existing Prime Vendor contract vehicle to supply 0.5mL doses of the tetanus, diphtheria, and pertussis vaccine to support DLA public health programs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a two day period concluding in mid-August 2023. No subcontractors or set aside designations were identified. This order enables DLA to maintain stockpile levels of important vaccines.

Generated 12/23/23, 3:10 PM